杉本　真也 （ スギモト　シンヤ ）

Sugimoto, Shinya

写真a

所属（所属キャンパス）

医学部 内科学教室（消化器） （ 信濃町 ）

職名

助教（有期）
Scopus 論文情報  
総論文数: 88 総引用数: 4477 h-index: 30

Click to view the Scopus page. The data was downloaded from Scopus API inMarch 01, 2026, via http://api.elsevier.com and http://www.scopus.com .

このページの先頭へ▲

学歴 【 表示 ／ 非表示 】

  • 2003年04月
    -
    2009年03月

    慶應義塾大学, 医学部

    大学, 卒業

  • 2014年04月
    -
    2018年03月

    慶應義塾大学, 医学研究科医学研究系専攻

    大学院, 修了, 博士

このページの先頭へ▲

学位 【 表示 ／ 非表示 】

  • 博士（医学）, 慶應義塾大学, 課程, 2018年03月

    Reconstruction of the Human Colon Epithelium In Vivo

このページの先頭へ▲
 

研究分野 【 表示 ／ 非表示 】

  • ライフサイエンス / 消化器内科学

このページの先頭へ▲

研究キーワード 【 表示 ／ 非表示 】

  • オルガノイド

  • 潰瘍性大腸炎関連腫瘍

  • 炎症性腸疾患

  • 短腸症候群

  • 腸管上皮幹細胞

このページの先頭へ▲
 

著書 【 表示 ／ 非表示 】

  • Organoid derivation and orthotopic xenotransplantation for studying human intestinal stem cell dynamics

    Sugimoto S., Fujii M., Sato T., Methods in Molecular Biology, 2020年

    　概要を見る

    Intestinal stem cells continuously self-renew throughout life to maintain gut homeostasis. With the advent of the organoid culture system, we are now able to indefinitely expand healthy and diseased tissue-derived human intestinal stem cells in vitro and use them for various applications. Nonetheless, investigating the behavior of human intestinal stem cells in vivo still remains challenging. We recently developed an orthotopic xenotransplantation system that realizes in vivo reconstruction of human intestinal epithelial tissue with preserved stem cell hierarchy by engrafting human normal colon organoids onto the mouse colon surface. We also introduced new growth factors, namely, insulin-like growth factor-1 (IGF-1) and fibroblast growth factor-2 (FGF-2), into the culture condition for human intestinal organoids that significantly increase scalability and transfectability of the organoids. By integrating these recent advances, we organized a tissue-oriented platform encompassing derivation of patient-derived intestinal organoids and their orthotopic xenotransplantation. The research platform based on orthotopic xenotransplantation of human intestinal organoids provides a powerful tool for studying human intestinal stem cell biology in native tissue-relevant contexts as well as for establishing novel disease modeling systems.

  • Establishment of 3D intestinal organoid cultures from intestinal stem cells

    Sugimoto S., Sato T., Methods in Molecular Biology, 2017年

    　概要を見る

    The intestinal epithelium is the most rapidly renewed tissue in adult mammals, and its renewal is strictly controlled by intestinal stem cells. Extensive studies using genetic models of intestinal epithelium have revealed the mechanisms underlying the self-renewal of intestinal stem cells. Exploiting this knowledge, we developed a novel 3D culture system that enables the outgrowth of intestinal Lgr5+ stem cells derived from mouse and human tissues into ever-expanding crypt–villus mini-guts, known as intestinal epithelial organoids. These organoids are maintained by the self-renewal of stem cells and give rise to all differentiated cell types of the intestinal epithelium. Once established, organoids can be cryopreserved and thawed when needed. This culture system has been widely used for studying stem cell behavior and gene function and for disease modeling.

このページの先頭へ▲

論文 【 表示 ／ 非表示 】

  • Evaluation of drug-induced lymphocyte stimulation test in mesalazine-associated allergic drug reaction

    Fukasawa N., Kiyohara H., Adachi T., Sugimoto S., Yoshimatsu Y., Murakami S., Mizushima I., Kaieda Y., Takabayashi K., Tsunoda J., Nakamoto N., Fukunaga K., Taguri M., Mikami Y., Kanai T.

    Journal of Allergy and Clinical Immunology Global 5 （ 2 ） 100625 2026年03月

    　概要を見る

    Background: 5-Aminosalicylic acid (5-ASA) is a fundamental drug for UC management; however, adverse reactions can lead to poor clinical outcomes and increased health care costs. No objective tests currently exist to predict adverse reactions. This study thus investigated 5-ASA across 4 formulations and addressed a key issue in the treatment of mild to moderate ulcerative colitis (UC). Objective: We aimed to examine the utility of the drug-induced lymphocyte stimulation test (DLST) in predicting successful rotation from mesalazine to sulfasalazine (SASP) in patients with UC. Methods: We retrospectively analyzed the largest cohort to date of patients with UC who were suspected of 5-ASA–associated adverse reactions and underwent DLST. We evaluated the DLST positivity rate for the suspected formulation, cross-reactivity to nonsuspected formulations, and clinical outcomes after rotation from mesalazine to SASP. Results: Mesalazine formulations exhibited a DLST positivity rate of 22.0% (18/82), with 45.1% (37/82) of patients testing positive for at least one 5-ASA formulation. Cross-reactivity between mesalazine and SASP was lower at 12.2% (10/82), likely because of structural differences. Adverse reactions typically developed within 2 weeks of initiating 5-ASA and commonly included fever, diarrhea, and bloody stool. Among patients with mesalazine-associated adverse reactions with DLST-negative test result for SASP, 8 of 12 tolerated the rotation. Rotation failure was mainly associated with a positive or borderline DLST result for mesalazine. Conclusions: DLST serves as a useful diagnostic tool for guiding treatment in patients with UC and suspected 5-ASA–associated hypersensitivity reactions. Prospective multicenter studies are needed to validate its clinical utility.

  • Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in Japan.

    Mizushima I, Yoshimatsu Y, Kiyohara H, Sugimoto S, Sujino T, Takabayashi K, Mikami Y, Kanai T

    Intestinal research 2026年02月

    ISSN  1598-9100

  • Niche-preserving transplantation promotes functional engraftment of intestinal organoids in rat short bowel syndrome

    Endo R., Sugimoto S., Kuwashima Y., Matano M., Hanyu H., Takahashi S., Kato H., Tanaka T., Sihombing A.M., Shirosaki K., Hatano Y., Sugiura Y., Kanai T., Wada M., Sato T.

    Cell Stem Cell 33 （ 1 ） 157 - 165.e6 2026年01月

    ISSN  19345909

    　概要を見る

    Short bowel syndrome (SBS) is a life-threatening condition in which outcomes often critically depend on ileal function, the only intestinal segment specialized for bile acid uptake and efficient fat absorption. However, whether restoring ileal epithelium-specific nutrient absorption can ameliorate SBS has remained unknown. Here, we demonstrate a niche-preserving transplantation strategy enabling highly efficient engraftment of intestinal organoids into the rat small intestine. Clearing luminal mucus with N-acetylcysteine facilitates ethylenediaminetetraacetic acid (EDTA)-based epithelial detachment, enabling removal of Lgr5<sup>+</sup> stem cells while preserving the stromal niche. This preconditioning increased the engrafted area and enabled the generation of an ilealized jejunum that improved body-weight trajectories and survival in rat SBS. Furthermore, the engrafted epithelia endowed the jejunum with bile acid absorption capacity. These findings provide in vivo evidence for stem cell niche theory, showing that the niche is essential to accommodate donor stem cells, and establish ilealized jejunum as a path toward autologous, region-targeted therapy for SBS.

  • Underestimation of the horizontal extent of ulcerative colitis-associated neoplasia may lead to incomplete endoscopic resection and subsequent recurrence.

    Murakami S, Sugimoto S, Iwao Y, Takabayashi K, Kiyohara H, Yoshimatsu Y, Sakakibara R, Kaieda Y, Shigehara A, Hosoe N, Kato M, Mikami Y, Kanai T

    Therapeutic advances in gastroenterology 19   17562848261416193 2026年

    ISSN  1756-283X

  • Characterization of Computed Tomography Colonography Findings of Ulcerative Colitis-Associated Neoplasia.

    Kaieda Y, Sugimoto S, Suzuki T, Matsumoto S, Kiyohara H, Takabayashi K, Yoshimatsu Y, Okabayashi K, Shigeta K, Sakakibara R, Wakisaka Y, Murakami S, Jinzaki M, Iwao Y, Mikami Y, Kanai T

    Inflammatory bowel diseases 2025年12月

    ISSN  1078-0998

全件表示 >>

このページの先頭へ▲

総説・解説等 【 表示 ／ 非表示 】

全件表示 >>

このページの先頭へ▲

競争的研究費の研究課題 【 表示 ／ 非表示 】

  • 疾患組織再構築による生体内での腸管病変の可視化

    2024年06月
    -
    2026年03月

    杉本 真也, 挑戦的研究（萌芽）, 補助金,  研究代表者

  • 細胞移植による腸管上皮機能の変換

    2023年04月
    -
    2026年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 杉本 真也, 基盤研究(B), 補助金,  研究代表者

  • 短腸症候群モデルを用いた新規移植療法の開発

    2021年07月
    -
    2023年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 杉本 真也, 挑戦的研究（萌芽）, 補助金,  研究代表者

  • 小腸上皮オルガノイドにより創出した移植グラフトの機能解析

    2020年04月
    -
    2023年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 杉本 真也, 基盤研究(B), 補助金,  研究代表者

  • 腸管AhRワールドの解明

    2019年02月
    -
    2021年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 金井 隆典, 国際共同研究加速基金(国際共同研究強化(B)), 研究分担者

全件表示 >>

このページの先頭へ▲

受賞 【 表示 ／ 非表示 】

  • 2025年度症例報告最優秀賞専修医部門 指導医

    2026年03月, 慶應大学医学部内科学教室

    受賞区分： 塾内表彰等

  • 第60回日本消化器免疫学会総会奨励賞

    2023年10月

    受賞区分： 国内学会・会議・シンポジウム等の賞

  • 第31回日本医学会総会奨励賞　内科領域

    2023年04月

    受賞区分： 国内学会・会議・シンポジウム等の賞

  • 若手奨励賞

    2022年10月, 第30回日本消化器関連学会週間（JDDW 2022 FUKUOKA）

    受賞区分： 国内学会・会議・シンポジウム等の賞

  • 第5回同窓会賞（基礎研究分野 猿田享男賞）

    2022年07月, 慶應義塾大学医学部内科学教室

    受賞区分： 塾内表彰等

全件表示 >>

このページの先頭へ▲
 

担当授業科目 【 表示 ／ 非表示 】

  • 内科学（消化器）講義

    2025年度

  • 内科学（消化器）講義

    2024年度

  • 内科学（消化器）講義

    2023年度

  • 内科学（消化器）講義

    2022年度

このページの先頭へ▲